Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors...

  • Main
  • 2020 / 05
  • Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors...

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Ezetimibe on Risk of New-Onset Diabetes: A Systematic Review and Meta-Analysis of Large, Double-Blinded Randomized Controlled Trials

Chiu, Sarah W., Pratt, Cristina M., Feinn, Richard, Chatterjee, Saurav
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Journal of Cardiovascular Pharmacology and Therapeutics
DOI:
10.1177/1074248420924983
Date:
May, 2020
File:
PDF, 332 KB
2020
Conversion to is in progress
Conversion to is failed